|Day Low/High||33.48 / 34.04|
|52 Wk Low/High||27.88 / 44.10|
The extent of the measures taken to combat the virus seem to be an overreaction, and no one should count on a vaccine being a magic bullet.
What if the market is simply pricing in a quarter that had already been priced out?
Equity markets had a tougher day on Wednesday than immediately meets the eye. And did you catch what Trump said?
I would wait until the next down day, and there will be one.
Do you know what a company does, does it do it well, and is there anything going on that could change the trajectory?
That's the really good news about why we could bounce back so quickly from Thursday's debacle.
The administration will provide increased financial support to 5 pharmas working on Covid vaccines, and we must keep an eye on price action in this uncertain market.
We're cheering what may be an aberration, a bullish employment number. We'll take what it brings - a wholesale shift in what we're buying and what we're selling to fund it.
Taking a chunk of Pfizer during this selloff, while Amazon has raised $10 billion in mixed-maturity debt and all eyes are on the government's response to civil unrest in the U.S.
WDAY looks ready to break out as traders weigh wether markets are now overbought after this 2-day run.
So what's the narrative? Simple: the recession is ending, it turned out to be a V recession and recovery after all.
I've been long Merck for a long time, since way before this pandemic became part of our lives.
The return of NYSE floor traders is symbolic of the return to normalcy, as vaccine candidate manufacturers are scaling up for mass production.
As State economies begin the slow process of reopening, the Fed is there to support market function. Facebook's latest e-commerce foray has investors cheering.
Let's step back and look at this market that has abandoned all sorts of safety and went all in on the stocks of companies based on the Fed's words and a promising Moderna study.
I'm long this name, as I am several of the others involved. Will I add on a day like this?
Jerome Powell hit the airwaves with some words of caution and comfort. Nvidia is running into earnings.
These high-quality companies have strong balance sheets and operate in high-demand markets poised to do well through any economic crisis.
Trump administration taps former GlaxoSmithKline exec as head of vaccine task force, and how I'm playing Walmart and Datadog.
Let's look at the stocks that will get crushed and that you can't touch right now.
I'm staying long this name, and I'm staying long PFE and JNJ, and I'm staying long GILD and ABT. You know why? Because I'm optimistic.
The bullish reversal pattern is appearing not just in single names, but also in whole sectors.
What's really driving the market, what's making the Nasdaq roar? Tech and science, that's what.
PFE is collaborating with German drugmaker BioNTech in the effort to find a well tolerated, effective vaccine.
There was a mild increase in trading volume at the New York Stock Exchange, but it was a rotational shift.
PFE's charts are constructive and traders could go long at current levels.
It's imperative that people get back to work, so we have this great compromise -- let's see how it might play out.